FLT3 and acute myeloid leukemia: Among the several different mutations associated with AML progressions, genetic alterations occurring in the FMS-like tyrosine kinase 3 (FLT3) gene is the most common known genetic marker diagnosed in both adult and pediatric AML patients [2,3].